EUVIMEDEUVIMED entdecken
Crossref

A retrospective study of papillary thyroid carcinoma: Hashimoto's thyroiditis as a protective biomarker for lymph node metastasis

Yu Wang, Jianwei Zheng, Xiaomeng Hu, Qing Chang, Yu Qiao, Xiaofeng Yao, Xuan Zhou

European Journal of Surgical Oncology · 2023-03 · 49 (3) · 560-567

DOI: 10.1016/j.ejso.2022.11.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Surgical Oncology, 2023-03. Verfasst von Yu Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Maxillofacial and Otorhinolaryngological Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research…. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Carcinoma, Papillary, Hashimoto Disease. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: There is approximately 10%-50% of papillary thyroid carcinoma (PTC) patients with Hashimoto's thyroiditis (HT). In this research, we sought to better understand the role of HT in PTC progression as well as lymph node metastasis. METHODS: It is a retrospective and cross-sectional study, and 4131 PTC patients who underwent thyroidectomy were finally enrolled. Chi-square test, univariate and multivariate logistic regression analyses were employed to evaluate both the risk factors and the critical roles of HT during PTC metastasis. RESULT: In this cohort, 1555 patients (37.6%) were diagnosed with HT. According to multivariate analysis, male sex, high levels of TG and TPOAb, tumor extrathyroidal extension, maximum diameter >1 cm, and multifocality were independent risk factors for both central lymph node metastasis (CLNM) and lateral lymph node metastasis (LLNM). In addition, age

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsCarcinoma, PapillaryHashimoto DiseaseHumansMaleMiddle AgedThyroid Cancer, PapillaryRetrospective StudiesLymphatic MetastasisCross-Sectional StudiesLymph NodesRisk FactorsBiomarkers

Stichwörter der Autor:innen

Central lymph node metastasisHashimoto's thyroiditisLateral lymph node metastasisPapillary thyroid carcinomaRisk factor

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Maxillofacial and Otorhinolaryngological Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, T…

Zitieren

APA

Wang, Y., Zheng, J., Hu, X., Chang, Q., Qiao, Y., Yao, X., & Zhou, X. (2023). A retrospective study of papillary thyroid carcinoma: Hashimoto's thyroiditis as a protective biomarker for lymph node metastasis. European Journal of Surgical Oncology, 49(3), 560-567. https://doi.org/10.1016/j.ejso.2022.11.014

Vancouver

Wang Y, Zheng J, Hu X, Chang Q, Qiao Y, Yao X, et al. A retrospective study of papillary thyroid carcinoma: Hashimoto's thyroiditis as a protective biomarker for lymph node metastasis. European Journal of Surgical Oncology. 2023;49(3):560-567. doi:10.1016/j.ejso.2022.11.014

BibTeX
@article{Wang2023,
  author = {Wang, Yu and Zheng, Jianwei and Hu, Xiaomeng and Chang, Qing and Qiao, Yu and Yao, Xiaofeng and Zhou, Xuan},
  title = {A retrospective study of papillary thyroid carcinoma: Hashimoto's thyroiditis as a protective biomarker for lymph node metastasis},
  journal = {European Journal of Surgical Oncology},
  year = {2023},
  volume = {49},
  number = {3},
  pages = {560--567},
  doi = {10.1016/j.ejso.2022.11.014}
}
Kostenlos starten →